<?xml version="1.0" encoding="UTF-8"?>
<ref id="B19-antibiotics-09-00909">
 <label>19.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bowen</surname>
    <given-names>A.C.</given-names>
   </name>
   <name>
    <surname>Tong</surname>
    <given-names>S.Y.</given-names>
   </name>
   <name>
    <surname>Andrews</surname>
    <given-names>R.M.</given-names>
   </name>
   <name>
    <surname>Oâ€™Meara</surname>
    <given-names>I.M.</given-names>
   </name>
   <name>
    <surname>McDonald</surname>
    <given-names>M.I.</given-names>
   </name>
   <name>
    <surname>Chatfield</surname>
    <given-names>M.D.</given-names>
   </name>
   <name>
    <surname>Currie</surname>
    <given-names>B.J.</given-names>
   </name>
   <name>
    <surname>Carapetis</surname>
    <given-names>J.R.</given-names>
   </name>
  </person-group>
  <article-title>Short-course oral co-trimoxazole versus intramuscular benzathine benzylpenicillin for impetigo in a highly endemic region: An open-label, randomised, controlled, non-inferiority trial</article-title>
  <source>Lancet</source>
  <year>2014</year>
  <volume>384</volume>
  <fpage>2132</fpage>
  <lpage>2140</lpage>
  <pub-id pub-id-type="doi">10.1016/S0140-6736(14)60841-2</pub-id>
  <pub-id pub-id-type="pmid">25172376</pub-id>
 </element-citation>
</ref>
